Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DEFIBROTIDE vs DEMCIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DEFIBROTIDE vs DEMCIZUMAB: Safety Overview

Metric DEFIBROTIDE DEMCIZUMAB
Total FAERS Reports 3,740 138
Deaths Reported 1,804 18
Death Rate 48.2% 13.0%
Hospitalizations 832 70
Average Patient Age 36.3 yrs 63.6 yrs
% Female Patients 38.7% 44.6%
FDA Approval Date Mar 30, 2016 N/A
Manufacturer Jazz Pharmaceuticals, Inc. N/A
Route INTRAVENOUS N/A
Marketing Status Prescription N/A